Porphyria cutanea tarda epidemiology and demographics: Difference between revisions
Created page with " __NOTOC__ ==Overview== '''Porphyria cutanea tarda''' (PCT) is the most common subtype of porphyria. The disorder results from low levels of the enzyme responsible f..." |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Porphyria cutanea tarda}} | |||
{{CMG}}; {{AE}} | |||
{{PleaseHelp}} | |||
==Overview== | ==Overview== | ||
'''Porphyria cutanea tarda''' (PCT) is the most common subtype of [[porphyria]]. The disorder results from low levels of the [[enzyme]] responsible for the [[uroporphyrinogen III decarboxylase|fifth step]] in [[heme]] production. Heme is a vital molecule for all of the body's organs. It is a component of [[hemoglobin]], the molecule that carries [[oxygen]] in the blood. | '''Porphyria cutanea tarda''' (PCT) is the most common subtype of [[porphyria]]. The disorder results from low levels of the [[enzyme]] responsible for the [[uroporphyrinogen III decarboxylase|fifth step]] in [[heme]] production. Heme is a vital molecule for all of the body's organs. It is a component of [[hemoglobin]], the molecule that carries [[oxygen]] in the blood. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
This type of porphyria occurs in an estimated 1 in 25,000 people, including both inherited and sporadic (noninherited) cases. An estimated 80 % of porphyria cutanea tarda cases are sporadic. The exact frequency is not clear because many people with the condition never experience symptoms. | This type of porphyria occurs in an estimated 1 in 25,000 people, including both inherited and sporadic (noninherited) cases. An estimated 80 % of porphyria cutanea tarda cases are sporadic. The exact frequency is not clear because many people with the condition never experience symptoms. | ||
| Line 10: | Line 13: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
[[Category:Endocrinology]] | |||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 19:26, 25 July 2016
|
Porphyria cutanea tarda Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Porphyria cutanea tarda epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Porphyria cutanea tarda epidemiology and demographics |
|
FDA on Porphyria cutanea tarda epidemiology and demographics |
|
CDC on Porphyria cutanea tarda epidemiology and demographics |
|
Porphyria cutanea tarda epidemiology and demographics in the news |
|
Blogs on Porphyria cutanea tarda epidemiology and demographics |
|
Risk calculators and risk factors for Porphyria cutanea tarda epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Porphyria cutanea tarda (PCT) is the most common subtype of porphyria. The disorder results from low levels of the enzyme responsible for the fifth step in heme production. Heme is a vital molecule for all of the body's organs. It is a component of hemoglobin, the molecule that carries oxygen in the blood.
Epidemiology and Demographics
This type of porphyria occurs in an estimated 1 in 25,000 people, including both inherited and sporadic (noninherited) cases. An estimated 80 % of porphyria cutanea tarda cases are sporadic. The exact frequency is not clear because many people with the condition never experience symptoms.